Cargando…
A large-scale organoid-based screening platform to advance drug repurposing in pancreatic cancer
Hirt et al.(1) report an automated, high-throughput drug screening platform for organoid cultures to enable repurposing of previously approved drugs for pancreatic cancers harboring specific genetic alterations. The pancreatic cancer organoid biobank also represents a valuable tool to uncover new dr...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903715/ https://www.ncbi.nlm.nih.gov/pubmed/36778660 http://dx.doi.org/10.1016/j.xgen.2022.100100 |